BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34245688)

  • 1. SLC37A4-CDG: New biochemical insights for an emerging congenital disorder of glycosylation with major coagulopathy.
    Raynor A; Haouari W; Ng BG; Cholet S; Harroche A; Raulet-Bussian C; Lounis-Ouaras S; Vuillaumier-Barrot S; Pascreau T; Borgel D; Freeze HH; Fenaille F; Bruneel A
    Clin Chim Acta; 2021 Oct; 521():104-106. PubMed ID: 34245688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mutation in SLC37A4 causes a dominantly inherited congenital disorder of glycosylation characterized by liver dysfunction.
    Ng BG; Sosicka P; Fenaille F; Harroche A; Vuillaumier-Barrot S; Porterfield M; Xia ZJ; Wagner S; Bamshad MJ; Vergnes-Boiteux MC; Cholet S; Dalton S; Dell A; Dupré T; Fiore M; Haslam SM; Huguenin Y; Kumagai T; Kulik M; McGoogan K; Michot C; Nickerson DA; Pascreau T; Borgel D; Raymond K; Warad D; ; Flanagan-Steet H; Steet R; Tiemeyer M; Seta N; Bruneel A; Freeze HH
    Am J Hum Genet; 2021 Jun; 108(6):1040-1052. PubMed ID: 33964207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum bikunin isoforms in congenital disorders of glycosylation and linkeropathies.
    Haouari W; Dubail J; Lounis-Ouaras S; Prada P; Bennani R; Roseau C; Huber C; Afenjar A; Colin E; Vuillaumier-Barrot S; Seta N; Foulquier F; Poüs C; Cormier-Daire V; Bruneel A
    J Inherit Metab Dis; 2020 Nov; 43(6):1349-1359. PubMed ID: 32700771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical diagnosis of congenital disorders of glycosylation.
    Raynor A; Haouari W; Lebredonchel E; Foulquier F; Fenaille F; Bruneel A
    Adv Clin Chem; 2024; 120():1-43. PubMed ID: 38762238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital disorders of glycosylation. Part I. Defects of protein N-glycosylation.
    Cylwik B; Naklicki M; Chrostek L; Gruszewska E
    Acta Biochim Pol; 2013; 60(2):151-61. PubMed ID: 23730680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic defects in dolichol metabolism.
    Buczkowska A; Swiezewska E; Lefeber DJ
    J Inherit Metab Dis; 2015 Jan; 38(1):157-69. PubMed ID: 25270028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SLC35A2-CDG: Functional characterization, expanded molecular, clinical, and biochemical phenotypes of 30 unreported Individuals.
    Ng BG; Sosicka P; Agadi S; Almannai M; Bacino CA; Barone R; Botto LD; Burton JE; Carlston C; Chung BH; Cohen JS; Coman D; Dipple KM; Dorrani N; Dobyns WB; Elias AF; Epstein L; Gahl WA; Garozzo D; Hammer TB; Haven J; Héron D; Herzog M; Hoganson GE; Hunter JM; Jain M; Juusola J; Lakhani S; Lee H; Lee J; Lewis K; Longo N; Lourenço CM; Mak CCY; McKnight D; Mendelsohn BA; Mignot C; Mirzaa G; Mitchell W; Muhle H; Nelson SF; Olczak M; Palmer CGS; Partikian A; Patterson MC; Pierson TM; Quinonez SC; Regan BM; Ross ME; Guillen Sacoto MJ; Scaglia F; Scheffer IE; Segal D; Singhal NS; Striano P; Sturiale L; Symonds JD; Tang S; Vilain E; Willis M; Wolfe LA; Yang H; Yano S; Powis Z; Suchy SF; Rosenfeld JA; Edmondson AC; Grunewald S; Freeze HH
    Hum Mutat; 2019 Jul; 40(7):908-925. PubMed ID: 30817854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling human congenital disorder of glycosylation type IIa in the mouse: conservation of asparagine-linked glycan-dependent functions in mammalian physiology and insights into disease pathogenesis.
    Wang Y; Tan J; Sutton-Smith M; Ditto D; Panico M; Campbell RM; Varki NM; Long JM; Jaeken J; Levinson SR; Wynshaw-Boris A; Morris HR; Le D; Dell A; Schachter H; Marth JD
    Glycobiology; 2001 Dec; 11(12):1051-70. PubMed ID: 11805078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and biochemical footprints of congenital disorders of glycosylation: Proposed nosology.
    Ng BG; Freeze HH; Himmelreich N; Blau N; Ferreira CR
    Mol Genet Metab; 2024 May; 142(1):108476. PubMed ID: 38653092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Komrower Lecture. Congenital disorders of glycosylation (CDG): it's all in it!
    Jaeken J
    J Inherit Metab Dis; 2003; 26(2-3):99-118. PubMed ID: 12889654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in TRAPPC11 are associated with a congenital disorder of glycosylation.
    Matalonga L; Bravo M; Serra-Peinado C; García-Pelegrí E; Ugarteburu O; Vidal S; Llambrich M; Quintana E; Fuster-Jorge P; Gonzalez-Bravo MN; Beltran S; Dopazo J; Garcia-Garcia F; Foulquier F; Matthijs G; Mills P; Ribes A; Egea G; Briones P; Tort F; Girós M
    Hum Mutat; 2017 Feb; 38(2):148-151. PubMed ID: 27862579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CDG biochemical screening: Where do we stand?
    Bruneel A; Cholet S; Tran NT; Mai TD; Fenaille F
    Biochim Biophys Acta Gen Subj; 2020 Oct; 1864(10):129652. PubMed ID: 32512173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TMEM165 deficiencies in Congenital Disorders of Glycosylation type II (CDG-II): Clues and evidences for roles of the protein in Golgi functions and ion homeostasis.
    Dulary E; Potelle S; Legrand D; Foulquier F
    Tissue Cell; 2017 Apr; 49(2 Pt A):150-156. PubMed ID: 27401145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-Glycosylation of Serum IgG and Total Glycoproteins in MAN1B1 Deficiency.
    Saldova R; Stöckmann H; O'Flaherty R; Lefeber DJ; Jaeken J; Rudd PM
    J Proteome Res; 2015 Oct; 14(10):4402-12. PubMed ID: 26401844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metalloglycobiology: The power of metals in regulating glycosylation.
    Durin Z; Houdou M; Legrand D; Foulquier F
    Biochim Biophys Acta Gen Subj; 2023 Sep; 1867(9):130412. PubMed ID: 37348823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of mass spectrometry in the diagnosis of congenital disorders of glycosylation.
    Sturiale L; Barone R; Garozzo D
    J Inherit Metab Dis; 2011 Aug; 34(4):891-9. PubMed ID: 21384227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory diagnosis of congenital disorders of glycosylation type I by analysis of transferrin glycoforms.
    Babovic-Vuksanovic D; O'Brien JF
    Mol Diagn Ther; 2007; 11(5):303-11. PubMed ID: 17963418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Metabolic Map into the Pathomechanism and Treatment of PGM1-CDG.
    Radenkovic S; Bird MJ; Emmerzaal TL; Wong SY; Felgueira C; Stiers KM; Sabbagh L; Himmelreich N; Poschet G; Windmolders P; Verheijen J; Witters P; Altassan R; Honzik T; Eminoglu TF; James PM; Edmondson AC; Hertecant J; Kozicz T; Thiel C; Vermeersch P; Cassiman D; Beamer L; Morava E; Ghesquière B
    Am J Hum Genet; 2019 May; 104(5):835-846. PubMed ID: 30982613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SLC37A4-CDG: Mislocalization of the glucose-6-phosphate transporter to the Golgi causes a new congenital disorder of glycosylation.
    Marquardt T; Bzduch V; Hogrebe M; Rust S; Reunert J; Grüneberg M; Park J; Callewaert N; Lachmann R; Wada Y; Engel T
    Mol Genet Metab Rep; 2020 Dec; 25():100636. PubMed ID: 32884905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complementation cloning identifies CDG-IIc, a new type of congenital disorders of glycosylation, as a GDP-fucose transporter deficiency.
    Lübke T; Marquardt T; Etzioni A; Hartmann E; von Figura K; Körner C
    Nat Genet; 2001 May; 28(1):73-6. PubMed ID: 11326280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.